Neurodegenerative Diseases
📧 Sign up to get email alerts when something new happens for Neurodegenerative Diseases.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-29Clinical Trial Results: A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation [Phase 2]
Phase 2 trial results for XPro1595 in early Alzheimer's disease with inflammatory biomarkers have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: NAD+ Oral Supplement Pilot Intervention in Adult Females [NA]
A completed pilot trial evaluated an NAD+ oral supplement in adult females for cognitive change and inflammation, with potential relevance t…
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: The Effects of the MIND Diet on Oxidative Stress, Inflammation and Neurodegenerative Risk Biomarkers [NA]
A completed clinical trial evaluated whether the MIND diet influences oxidative stress, inflammation, and neurodegenerative risk biomarkers.
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Novel Diagnostic and Disease Stage Biomarkers in AD
The update indicates the completed trial from the Danish Dementia Research Centre evaluating novel diagnostic and disease-stage biomarkers f…
-
CLINICAL_TRIALS trial_result · 2024-07-19Clinical Trial Update: Cord Blood Serum in the Treatment of Neuro-Degenerative Ophthalmic Diseases. 1-Glaucoma [NA]
Clinical trial evaluating cord blood serum for glaucoma and other neurodegenerative ophthalmic diseases has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: [18F]MC225-PET in Neurodegenerative Disease [Phase 1, Phase 2]
Early-phase trial update for [18F]MC225-PET imaging in neurodegenerative diseases, including Alzheimer’s disease and related conditions (Pha…
-
CLINICAL_TRIALS trial_result · 2022-11-25Clinical Trial Update: Smell, Voice and Nasal Swabs as Markers for Neuro-degenerative Disorders [NA]
Clinical trial update on using smell, voice, and nasal swabs as markers for neuro-degenerative disorders; status completed with results post…
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: [18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative Disease [Phase 2]
Phase 2 clinical trial update for [18F]THK-5351 PET imaging across Alzheimer's disease, mild cognitive impairment, and other neurodegenerati…
-
CLINICAL_TRIALS trial_result · 2014-04-10Clinical Trial Update: Biodistribution and Safety of a Radiopharmaceutical in Healthy Subjects [Phase 1]
Phase 1 study in healthy subjects evaluated biodistribution and safety of a radiopharmaceutical; status completed with initial safety and ph…
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: Yogic Breathing Changes Salivary Components [NA]
This completed clinical trial examined whether yogic breathing changes salivary components.
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's Disease [Phase 4]
Clinical trial NCT01662414, sponsored by Chulalongkorn University, evaluated HMS 90 undenatured cysteine-rich whey protein isolate in Parkin…
-
CLINICAL_TRIALS trial_result · 2012-10-01Clinical Trial Update: The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD
This clinical trial update reports the long-term safety and efficacy follow-up of subjects who completed the Phase I study of Neurostem-AD.